Results per Page:
Dr. Lawrence Fong, new Fred Hutch immunotherapy director, talks about how the field has transformed oncology
In-house grant funding program will underpin efforts to advance therapies to clinical trials
Dr. Mazyar Shadman, new medical director of the Bezos Family Immunotherapy Clinic, says immunotherapy services are expanding to meet demand
Increasing timely access to immunotherapy is a main goal
Safety and feasibility approved for new therapy to treat relapsed hematologic malignancies
From the Bleakley Lab, Translational Science & Therapeutics Division
Cost-effective device trains immune cells to kill tumor cells
From the Matthias Stephan Lab, Translational Science & Therapeutics Division
How a Black woman is coping with an ‘old white man’s disease’
Bladder cancer patient manages the stress of a disease where recurrence is common
Diagnosed with stage 4 kidney cancer, a woman is disease-free after immunotherapy
Treatment includes a unique approach to reduced-frequency dosing
Boosting the effectiveness of CAR T-cell therapies against AML
Dr. Erik Kimble wins award from the American Society of Gene & Cell Therapy
Bioengineer Aaron Ring receives Anderson Family Endowed Chair for Immunotherapy
Chair will support innovative immunotherapeutic approaches to cancer drug target discovery
MacPherson Lab puts immunologically cold cancers in the hot seat with combination therapy
From the MacPherson and Srivastava Labs, Cancer Basic Biology and Cancer Immunology Programs, Cancer Consortium.
Fred Hutch mourns sudden loss of Dr. Martin ‘Mac’ Cheever
A long career devoted to bringing immunotherapies from bench to bedside
How RNA-altering drugs might improve anticancer immunotherapies
In lab study, brief disruptions of gene machinery make tumor cells more 'visible' to immune system
Tip Sheet: Latest research on COVID-19, health disparities, antibodies to parainfluenza, and neuron function
Summaries of recent Fred Hutch research findings and other news
Self-assembling, donut-shaped nanoparticles form novel platform for development of new biomolecules
Scientist-designed protein scaffolds offer several advantages over molecular backbone currently used in research and clinical applications
Cancer immunotherapy gets assist from micro-scale engineering
With new molecular 'handles' and stimulating signals, metallic thin films become a stronghold for cancer-killing immune cells
Fred Hutch collaborates with new Allen Institute for Immunology
Multi-collaborator initiative aims to map the immune system in health and disease
Dr. Matthias Stephan named Allen Distinguished Investigator
The $1.5 million award will help translate cutting-edge nanoparticle immunotherapy approach to the clinic